{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T11:29:07Z","timestamp":1772450947336,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.numecd.2023.09.016","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T06:18:13Z","timestamp":1695363493000},"page":"404-417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between circulating biomarkers and non-alcoholic fatty liver disease: An integrative Mendelian randomization study of European ancestry"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0112-5652","authenticated-orcid":false,"given":"Dongze","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2023.09.016_bib1","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/HYPERTENSIONAHA.122.17982","article-title":"Nonalcoholic fatty liver disease and cardiovascular disease: a review of shared cardiometabolic risk factors","volume":"79","author":"Muzurovi\u0107","year":"2022","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"key":"10.1016\/j.numecd.2023.09.016_bib2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2147\/CLEP.S403314","article-title":"Association between serum uric acid and non-alcoholic fatty liver disease: an updated systematic review and meta-analysis","volume":"15","author":"Sun","year":"2023","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.numecd.2023.09.016_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"The lancet Gastroenterology & hepatology"},{"key":"10.1016\/j.numecd.2023.09.016_bib4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jhep.2021.10.029","article-title":"Non-invasive evaluation of response to obeticholic acid in patients with NASH: results from the REGENERATE study","volume":"76","author":"Rinella","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2023.09.016_bib5","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/hep.30590","article-title":"NGM282 improves liver fibrosis and histology in 12 Weeks in patients with nonalcoholic steatohepatitis","volume":"71","author":"Harrison","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2023.09.016_bib6","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.numecd.2023.09.016_bib7","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling variability of liver biopsy in nonalcoholic fatty liver disease","volume":"128","author":"Ratziu","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.numecd.2023.09.016_bib8","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1016\/j.cgh.2019.02.024","article-title":"Reduced patient-reported outcome scores associate with level of fibrosis in patients with nonalcoholic steatohepatitis","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol : the official clinical practice journal of the American Gastroenterological Association"},{"key":"10.1016\/j.numecd.2023.09.016_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12050440","article-title":"Mendelian randomization analysis identifies blood tyrosine levels as a biomarker of non-alcoholic fatty liver disease","volume":"12","author":"Gobeil","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.numecd.2023.09.016_bib10","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/ajcn\/nqac285","article-title":"Homocysteine, folate, and nonalcoholic fatty liver disease: a systematic review with meta-analysis and Mendelian randomization investigation","volume":"116","author":"Yuan","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.numecd.2023.09.016_bib11","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2020.11.028","article-title":"Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance","volume":"74","author":"Wang","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2023.09.016_bib12","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1136\/gutjnl-2017-313778","article-title":"Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase\/hydrogen sulfide pathway","volume":"67","author":"Li","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.numecd.2023.09.016_bib13","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1111\/liv.13144","article-title":"Elevated serum ferritin is associated with increased mortality in non-alcoholic fatty liver disease after 16 years of follow-up","volume":"36","author":"Hagstr\u00f6m","year":"2016","journal-title":"Liver Int : official journal of the International Association for the Study of the Liver"},{"key":"10.1016\/j.numecd.2023.09.016_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.livres.2021.03.004","article-title":"Vitamins and non-alcoholic fatty liver disease: a Molecular Insight(\u22c6)","volume":"5","author":"Raza","year":"2021","journal-title":"Liver research"},{"key":"10.1016\/j.numecd.2023.09.016_bib15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/gut.2003.024935","article-title":"Cytokines and the pathogenesis of non-alcoholic steatohepatitis","volume":"54","author":"Diehl","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.numecd.2023.09.016_bib16","series-title":"FinnGen: unique genetic insights from combining isolated population and national health register data","author":"Kurki","year":"2022"},{"key":"10.1016\/j.numecd.2023.09.016_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jhep.2020.04.003","article-title":"Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort(\u2606)","volume":"73","author":"Anstee","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2023.09.016_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep4.1805","article-title":"Genome-wide association study of NAFLD using electronic Health records","volume":"6","author":"Fairfield","year":"2022","journal-title":"Hepatology communications"},{"key":"10.1016\/j.numecd.2023.09.016_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hep.29465","article-title":"Altered amino acid concentrations in NAFLD: impact of obesity and insulin resistance","volume":"67","author":"Gaggini","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2023.09.016_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cyto.2013.02.020","article-title":"Glutamine and alanine-induced differential expression of intracellular IL-6, IL-8, and TNF-\u03b1 in LPS-stimulated monocytes in human whole-blood","volume":"62","author":"Rasp\u00e9","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.numecd.2023.09.016_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030705","article-title":"Non-alcoholic fatty liver disease and risk of incident type 2 diabetes: role of circulating branched-chain amino acids","volume":"11","author":"van den Berg","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.numecd.2023.09.016_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","article-title":"Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)","volume":"48","author":"Musso","year":"2009","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.numecd.2023.09.016_bib23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10654-022-00868-3","article-title":"Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study","volume":"37","author":"Yuan","year":"2022","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.numecd.2023.09.016_bib24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.32728","article-title":"The associations between modifiable risk factors and nonalcoholic fatty liver disease: a comprehensive Mendelian randomization study","volume":"77","author":"Xie","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2023.09.016_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/nu14204434","article-title":"Role of inflammatory factors in mediating the effect of lipids on nonalcoholic fatty liver disease: a two-step, multivariable mendelian randomization study","volume":"14","author":"Chen","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.numecd.2023.09.016_bib26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","author":"Kawano","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.numecd.2023.09.016_bib27","doi-asserted-by":"crossref","first-page":"E852","DOI":"10.1152\/ajpendo.00193.2019","article-title":"HDL flux is higher in patients with nonalcoholic fatty liver disease","volume":"317","author":"McCullough","year":"2019","journal-title":"Am J Physiol Endocrinol Metabol"},{"key":"10.1016\/j.numecd.2023.09.016_bib28","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1111\/liv.14597","article-title":"NAFLD is related to post-prandial triglyceride-enrichment of HDL particles in association with endothelial and HDL dysfunction","volume":"40","author":"Verwer","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.numecd.2023.09.016_bib29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.atherosclerosis.2013.12.013","article-title":"Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance?","volume":"233","author":"Li","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2023.09.016_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.24706","article-title":"Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"55","author":"Kowdley","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2023.09.016_bib31","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.cgh.2013.11.035","article-title":"Serum ferritin levels lack diagnostic accuracy for liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"12","author":"Angulo","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2023.09.016_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hep.20023","article-title":"Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver","volume":"39","author":"Bugianesi","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2023.09.016_bib33","doi-asserted-by":"crossref","first-page":"10387","DOI":"10.1038\/s41598-021-89991-x","article-title":"Serum iron and risk of nonalcoholic fatty liver disease and advanced hepatic fibrosis in US adults","volume":"11","author":"Yang","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.numecd.2023.09.016_bib34","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/hep.24038","article-title":"Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease","volume":"53","author":"Nelson","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2023.09.016_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12986-022-00715-y","article-title":"Association between iron metabolism and non-alcoholic fatty liver disease: results from the National Health and Nutrition Examination Survey (NHANES 2017-2018) and a controlled animal study","volume":"19","author":"Zhang","year":"2022","journal-title":"Nutr Metab"},{"key":"10.1016\/j.numecd.2023.09.016_bib36","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.2019002907","article-title":"Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis","volume":"136","author":"Yu","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.numecd.2023.09.016_bib37","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12944-017-0613-4","article-title":"Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis","volume":"16","author":"Du","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.numecd.2023.09.016_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237104","article-title":"Iron deposition in autopsied liver specimens from older patients receiving intravenous iron infusion","volume":"15","author":"Akatsu","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2023.09.016_bib39","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cmet.2022.07.006","article-title":"Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis","volume":"34","author":"Gao","year":"2022","journal-title":"Cell Metabol"},{"key":"10.1016\/j.numecd.2023.09.016_bib40","doi-asserted-by":"crossref","first-page":"101235","DOI":"10.1016\/j.molmet.2021.101235","article-title":"Iron aggravates hepatic insulin resistance in the absence of inflammation in a novel db\/db mouse model with iron overload","volume":"51","author":"Altamura","year":"2021","journal-title":"Mol Metabol"},{"key":"10.1016\/j.numecd.2023.09.016_bib41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ebiom.2017.12.027","article-title":"Vitamin D and nonalcoholic fatty liver disease: Bi-directional mendelian randomization analysis","volume":"28","author":"Wang","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.numecd.2023.09.016_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/nu12072097","article-title":"Immunologic effects of vitamin D on human Health and disease","volume":"12","author":"Charoenngam","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.numecd.2023.09.016_bib43","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.3748\/wjg.v23.i19.3407","article-title":"Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease","volume":"23","author":"Cimini","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.numecd.2023.09.016_bib44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2147\/DMSO.S286334","article-title":"The impact of vitamin D in non-alcoholic fatty liver disease: a cross-sectional study in patients with morbid obesity","volume":"14","author":"Borges-Canha","year":"2021","journal-title":"Diabetes, Metab Syndrome Obes Targets Ther"},{"key":"10.1016\/j.numecd.2023.09.016_bib45","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12916-016-0638-y","article-title":"No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial","volume":"14","author":"Barchetta","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.numecd.2023.09.016_bib46","doi-asserted-by":"crossref","first-page":"1054159","DOI":"10.3389\/fimmu.2022.1054159","article-title":"Association of complement components with the risk and severity of NAFLD: a systematic review and meta-analysis","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.numecd.2023.09.016_bib47","doi-asserted-by":"crossref","first-page":"23279","DOI":"10.1038\/srep23279","article-title":"Serum complement C3 levels are associated with nonalcoholic fatty liver disease independently of metabolic features in Chinese population","volume":"6","author":"Xu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.numecd.2023.09.016_bib48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s43657-021-00023-0","article-title":"Causal relationship between complement C3, C4, and nonalcoholic fatty liver disease: bidirectional mendelian randomization analysis","volume":"1","author":"Li","year":"2021","journal-title":"Phenomics"},{"key":"10.1016\/j.numecd.2023.09.016_bib49","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jhep.2011.10.005","article-title":"Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans","volume":"56","author":"Pihlajam\u00e4ki","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2023.09.016_bib50","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.numecd.2023.09.016_bib51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1359-6101(02)00020-5","article-title":"The balance between IL-1 and IL-1Ra in disease","volume":"13","author":"Arend","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.numecd.2023.09.016_bib52","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/j.gastro.2012.02.003","article-title":"Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications","volume":"142","author":"Cusi","year":"2012","journal-title":"Gastroenterology"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475323003770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475323003770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T03:36:32Z","timestamp":1746761792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475323003770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0939475323003770"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2023.09.016","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between circulating biomarkers and non-alcoholic fatty liver disease: An integrative Mendelian randomization study of European ancestry","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2023.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}